Rehabilitation for Ataxia Following Chemotherapy for Burkitt Lymphoma Involving the Rectum.
10.5535/arm.2012.36.4.578
- Author:
Hyoung Seop KIM
1
;
Chul Oh JUNG
;
Ha Ra JEON
;
Lee Ho SUNG
Author Information
1. Department of Physical Medicine and Rehabilitation, National Health Insurance Corporation Ilsan Hospital, Korea.
- Publication Type:Case Report
- Keywords:
Cytarabine;
Cerebellar toxicity;
Ataxia
- MeSH:
Adult;
Ataxia;
Burkitt Lymphoma;
Cecum;
Central Nervous System;
Child;
Cytarabine;
Dysarthria;
Humans;
Ileum;
Lethargy;
Lymphoma, B-Cell;
Rectum
- From:Annals of Rehabilitation Medicine
2012;36(4):578-583
- CountryRepublic of Korea
- Language:English
-
Abstract:
Burkitt lymphoma is a type of B-cell lymphoma that occurs mostly in children, and rarely in adults. The sporadic type is known to occur mostly at the ileum and cecum. Cytarabine, which is used for central nervous system prophylaxis during chemotherapy for Burkitt lymphoma, has known neurotoxicity, and its side effects include motor ataxia due to cerebellar injury, ataxic dysarthria, dysfunction of ocular movement, confusion, somnolence and lethargy. This case report is about a patient diagnosed with Burkitt lymphoma who manifested motor ataxia after chemotherapy that included cytarabine.
